PROVIDER PROFILE · NPI 1861580367

Rae AranasM.D.

PRACTICEPRIMARY PAIN CONSULTANTS LLCSee all providers at this practice →

Interventional Pain ManagementBridgewater, NJI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

239

Unique beneficiaries

—

Total services

1,763

Distinct HCPCS

Medicare payment

$58K

Peer benchmark

Total Medicare services vs. 50 Interventional Pain Management providers in NJ — above median (cohort median 1,760).

PRESCRIBING · PART D · 2024

Total Rx claims

523

Beneficiaries

—

Total drug cost

$26K

Distinct drugs

Brand share

30.0%

Top prescribed drugs

Tramadol Hcl79 claims

Oxycodone Hcl/Acetaminophen76 claims

Hydrocodone/Acetaminophen68 claims

Gabapentin52 claims

Pregabalin52 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$679

Payment records

By payment type

Food and Beverage$461

Travel and Lodging$217

REFERRAL NETWORK

Where Rae Aranas's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Somerset Outpatient Surgery, Llc Ambulatory Surgical Center · Somerset, NJ	31	249
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	16	59
ROBERT WOOD JOHNSON UNIVERSITY HOSPITAL INC	13	38
Phoenix Toxicology & Lab Services Clinical Laboratory · Phoenix, AZ	13	51

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history